Stiripentol-d9

• CAT Number: R011281
• CAS Number: 1185239-64-8
• Molecular Formula: C₁₄H₉D₉O₃
• Molecular Weight: 243.35
• Purity: ≥95%
• Synonyms: 1-(1,3-Benzodioxol-5yl)-4,4-dimethyl-1-penten-3-ol-d9; 4,4-Dimethyl-1-(3,4-methylenedioxyphenyl)-1-penten-3-ol-d9; BCX 2600-d9
• Storage: -20°C
• IUPAC Name: (E)-1-(1,3-benzodioxol-5-yl)-5,5,5-trideuterio-4,4-bis(trideuteriomethyl)pent-1-en-3-ol
• InChI: InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+/i1D3,2D3,3D3
• InChIKey: IBLNKMRFIPWSOY-QPYRMXHWSA-N
• SMILES: [2H]C([2H])([2H])C(C(/C=C/C1=CC2=C(C=C1)OCO2)O)(C([2H])([2H])[2H])C([2H])([2H])[2H]

Stiripentol-d9（Cat No.:R011281） is a deuterated form of Stiripentol, an antiepileptic drug known for its efficacy in treating Dravet syndrome and other refractory epilepsies. Incorporating nine deuterium atoms, this isotopically labeled compound offers enhanced stability and precise analytical performance. It is instrumental in pharmacokinetic studies, metabolic pathway analysis, and drug development. Stiripentol-d9 ensures accurate tracing in biological systems, facilitating advanced research. Ideal for pharmaceutical and biochemical applications, it supports high-precision investigations, contributing to the development of safer and more effective therapeutic agents.